Neuroloxía

2024

1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

2. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

   npj Parkinson's Disease, Vol. 10, Núm. 1

3. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale

   Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2

4. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

   Neuromuscular Disorders, Vol. 34, pp. 1-8

5. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

   Frontiers in Neurology , Vol. 15

6. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

   Molecular Metabolism, Vol. 79

7. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain

   Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1

8. New Perspectives in Neuroprotection for Ischemic Stroke

   Neuroscience

9. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models

   Stem Cell Research and Therapy, Vol. 15, Núm. 1

10. Oral anticoagulants: A plausible new treatment for Alzheimer's disease?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 760-776

11. Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke

    Journal of Cerebral Blood Flow and Metabolism

12. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

13. Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

    Frontiers in Neurology , Vol. 15

14. Seizures in the emergency department: clinical and therapeutic characteristics of 122 patients

    Revista de Neurologia, Vol. 78, Núm. 5, pp. 121-125

15. Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)

    Trials, Vol. 25, Núm. 1

16. Systemic biomarker associated with poor outcome after futile reperfusion

    European Journal of Clinical Investigation, Vol. 54, Núm. 6

17. The role of the brain renin-angiotensin system in Parkinson´s disease

    Translational Neurodegeneration, Vol. 13, Núm. 1

18. Therapeutic inertia in the management of neuromyelitis optica spectrum disorder

    Frontiers in Neurology , Vol. 15

19. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

20. Vaccine Safety and Immunogenicity in Patients with Multiple Sclerosis Treated with Natalizumab

    JAMA Network Open, Vol. 7, Núm. 4, pp. E246345